Top Banner
2 ND NOV 2010 1
18

Ppt 4

Nov 01, 2014

Download

Business

hmm about quality control of pharmaceutical aerosols
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Ppt 4

2ND NOV 2010 1

Page 2: Ppt 4

Aerosols: are products that are packaged under pressure and contain therapeutically active ingredients that are released upon activation of an appropriate valve system.

The basic components of an aerosol system are the container, the propellant, the concentrate containing the active ingredient(s),The valve, and the actuator.

2ND NOV 20102

Page 3: Ppt 4

Aerosol characteristics:Particle size distributionUniformity of dose for metered valveDelivery rateWetness and temperature of the spraySpray patternVelocity of sprayFoam densityFluid viscosity

;

2ND NOV 20103

Page 4: Ppt 4

Aerosol components• Propellants: Halogenated derivative of hydrocarbonsLow molecular weight hydrocarbons: butane,

pentaneCompressed gas

Test for propellants • Vapour pressure• Density• Gas chromatography test for purity• Moisture, halogen, non-volatile residue

2ND NOV 20104

Page 5: Ppt 4

Valves: to regulate the flow of the therapeutic agent and

propellant from the containerMaterials used for the manufacturing of valve

should be inert to the formulations used. Plastic, rubber, aluminum, stainless steel valve

components are used. Continuous spray valve: used on topical productsMetered-dose valve : must deliver an accurate dose

within specified tolerance

2ND NOV 20105

Page 6: Ppt 4

Extractable substances• Leaching of extractable from plastic components into the

formulation is a potential serious problem.• Extractable include: antioxidants, plasticizers, monomers,

nitrosamine, vulcanization accelerators, etc., should be identified and minimized.

• The composition and the quality of materials used in the manufacturing of the valve components must be carefully selected and controlled. Their compatibility with formulation components should be well established to minimize change in the medication delivery, leak rate, impurity profile of the drug product over time.

2ND NOV 20106

Page 7: Ppt 4

Actuators: is the fitting attached to an aerosol valve stem, which when depressed or moved, open the valve, and directs the spray containing the drug preparation to the desired area.

Containers:Made of glass, plastic or metal as stainless steel, aluminum, tin.Extractable or leachable and particulates on the internal surfaces of containers should be controlled.

Manufacturing process controls usually include: monitoring of proper formulation and propellant fill weight and pressure testing, leak testing, and valve function testing of the finished aerosol.

2ND NOV 20107

Page 8: Ppt 4

Topical Aerosols Delivery rate and delivered amountOnly perform these tests on containers fitted with continuous valves.Procedure: Select not less than 4 aerosol containers, weigh, actuate each valve for 5 seconds, weigh each container again.Calculate the average delivery rate in g per second, for each container.Calculate the total weight loss from the container. This is the delivered amount. 

2ND NOV 20108

Page 9: Ppt 4

Pressure test Only perform this test on topical aerosols fitted with

continuous valves. Select 4 aerosol containers, determine the pressure in each

container by placing a calibrated pressure gauge on the valve stem.

 

2ND NOV 20109

Page 10: Ppt 4

Leakage TestOnly perform on topical aerosols fitted with continuous valves.Select 12 aerosol containers, weigh each container, mg W1, allow to stand in upright position at temp. 25C for not less than 3 days, weigh again each container, record the weight, mg as W2, calculate the leakage rate mg/year. 365x(24/t) (W1-w2)

2ND NOV 201010

Page 11: Ppt 4

If 1 container leaks more than 5% per year, and if none of the containers leaks more than 7% per year.Determine the leakage rate of an additional 24 containers as directed. Not more than 2 of the 36 containers leak more than 5% of the net fill weight per year, and none of the 36 containers leaks more than 7% of the net fill weight per year. 

2ND NOV 201011

Page 12: Ppt 4

Flame extension test The product is sprayed for 4 seconds into a flame, the

extension of the flame is measured by a ruler.  Spray pattern test By spraying the content of the container on a rotating paper

impregnated with a dye solution, coloured spots are produced Homogeneity of the colour indicates a homogenous spray pattern.

 

2ND NOV 201012

Page 13: Ppt 4

Total number of discharges per container• Perform this test on topical aerosols fitted with dose-metering

valves. • The requirements are met if all the containers or inhalers

tested contain not less than the number of discharges stated on the label.

 

2ND NOV 201013

Page 14: Ppt 4

Uniformity of dosage units The test is required for aerosols fitted with dose-metered

valves, metered dose inhaler and dry powder inhalers. The drug content of atleast 9 of the 10 doses collected from

one inhaler, are between 75% and 125% of label claim, and none is outside the range of 65% to 135% of the label claim.

If the contents of not more than 3 doses are outside the range of 75% to 125%, but within the range of 65% to 135% of label claim, select 2 additional inhalers and follow the procedure for analyzing 10 doses from each.

The requirements are met if not more than 3 results, out of the 30 values, lie outside the range of 75% to 125% of label claim and none is outside the range of 65%to 135% of label claim.

 

2ND NOV 201014

Page 15: Ppt 4

Particle size• The particle or droplet size distribution in the spray

discharged from metered-dose inhalers or from dry powder inhalers are important characteristics used in judging inhaler performance.

  

2ND NOV 201015

Page 16: Ppt 4

2ND NOV 201016

Page 17: Ppt 4

2nd nov 2010 17

“The Theory & Practice Of Industrial Pharmacy” by Leon Lachman, H.A.Liberman, Joseph Kanig, 3rd

Edition, Varghese Pub., page no. 613-618.

Remington’s “The Science & Practice Of Pharmacy” 3rd Edition, Volume-I, page no.1014-

1015

Page 18: Ppt 4

2nd nov 2010 18